Abstract:The present study was performed to assess the prognostic factors with respect to patient survival and clinicopathological characteristics for patients who underwent surgery for pancreatic neuroendocrine tumors (PNETs). A retrospective review of patients pathologically diagnosed with PNETs at the First Affiliated Hospital, Zhejiang University School of Medicine (Hangzhou, Zhejiang, China) between September 2002 and September 2013 was conducted. The clinicopathological findings, overall survival (OS) rate and disease-free survival (DFS) rate of the patients with PNETs were analyzed. Prognostic factors were determined by univariate and multivariate analyses. A total of 104 patients were selected. The median age at presentation was 52 years (range, 19-76 years). The most common surgical procedure was distal pancreatectomy (51.0%), followed by pancreaticoduodenectomy (27.9%) and local resection of the pancreas (16.3%). The majority of the tumors were of low or moderate grade (93.3%, grade 1 or 2) and were local or regional stage (92.3%). The 1-, 3-and 5-year OS rates were 95, 85 and 73%, respectively. Meanwhile, the 1-, 3-and 5-year DFS rates were 86, 72 and 68%, respectively. The OS and DFS rates were significantly different with regard to the grade (grades 1, 2 and 3; P< 0.001) and stage (local, regional and distant disease; P<0.001). Furthermore, patients with a low Ki-67 index experienced superior OS and DFS rates compared with patients with a high Ki-67 index (P<0.001). The presence of lymph node metastasis was predictive of inferior OS and DFS rates compared with the absence of lymph node metastasis (P<0.001). OS rate for PNETs was significantly affected by resection margin status (P<0.001). In multivariable analysis, the significant factors associated with OS rate were stage (P= 0.02), grade (P< 0.001), lymph node status (P=0.025), Ki-67 index (P=0.031) and resection margin status (P< 0.001). Meanwhile, stage (P=0.001), grade (P=0.017), lymph node status (P=0.02) and Ki-67 index (P=0.016) were prognostic factors for DFS rate. In conclusion, grade, stage, Ki-67 index and lymph node involvement are significant prognostic factors for OS and DFS rates in surgically resectable PNETs. Furthermore, surgical margin status may also be an independent predictor for the prognosis of PNETs. It is anticipated that these findings may provide useful predictors of clinical survival, particularly in the setting of resected disease.

Clinicopathological Features and Long-Term Prognosis of Purely Cystic Pancreatic Neuroendocrine Tumors: A Single-Center Experience.

Analysis of clinical features and prognosis in 126 patients with peripheral primitive neuroectodermal tumor

Survival Outcomes and Surgical Intervention of Small Intestinal Neuroendocrine Tumors: a Population Based Retrospective Study

Cystic Pancreatic Neuroendocrine Tumors: A Distinctive Subgroup with Indolent Biological Behavior? A Systematic Review and Meta-Analysis.

Clinicopathological characteristics and prognosis-related factors of resectable pancreatic neuroendocrine tumors: a retrospective study of 104 cases in a single Chinese center.

Epidemiology, diagnosis, surgical treatment and prognosis of the pancreatic neuroendocrine tumors: Report of 125 patients from one single center.

[The Diagnosis and Treatment of Pancreatic Neuroendocrine Neoplasms].

Analysis of clinical characteristics and prognosis of 63 cases of pancreatic neuroendo-crine tumor

[Clinical Analysis of Minimal Invasive Surgical Treatment for Pancreatic Neuroendocrine Tumors].

Surgical Treatment and Clinical Outcome of Nonfunctional Pancreatic Neuroendocrine Tumors: a 14-Year Experience from One Single Center.

Clinical Outcomes and Prognostic Factors of Resected Pancreatic Neuroendocrine Neoplasms: A Single-Center Experience in China.

Prognostic Factors of Long-Term Outcome in Surgically Resectable Pancreatic Neuroendocrine Tumors: A 12-Year Experience from A Single Center

Prognostic Factors and Survival in Patients with Neuroendocrine Tumors of the Pancreas

Clinical Features Of Patients With Pancreatic Neuroendocrine Neoplasms: A Retrospective Analysis Of 61 Cases In A Cancer Center

Clinicopathological Characteristics and Survival Outcomes of Primary Hepatic Neuroendocrine Tumor: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Study

Minimal Invasive Surgery in the Treatment of Neuroendocrine Tumors of the Pancreas

Analysis of Risk Factors Affecting the Prognosis of Pancreatic Neuroendocrine Tumors

Recent Advance in Surgical Treatment of Pancreatic Neuroendocrine Tumors

Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis

Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine tumors: analysis from a single-institution.

Risk Of Malignancy And Prognosis Of Sporadic Resected Small (<= 2 Cm) Nonfunctional Pancreatic Neuroendocrine Tumors